drugset / Trial / NCT03772951

The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia

NCT03772951

Phase 4 Completed 154 enrolled Shanghai Mental Health Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The study group received antipsychotic drugs combined with Computerized Cognitive Remediation Therapy (CCRT) for 4 times/week for 45 minutes each time. The control group only received antipsychotic drugs. For a total of 12 weeks. Brain Derived Neurotrophic Factor (BDNF) and Tropomyosin-related kinase B (Trk B) genes in peripheral blood were detected in both groups before and after treatment. Clinical symptoms and executive function assessment were performed in both groups before and after treatment. The relevance of genes and their effects on downstream protein expression levels led to a molecular genetic mechanism for the efficacy of Computerized Cognitive Remediation Therapy (CCRT) .

Timeline

Start
2019-01-10
Primary completion
2021-03-31
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clozapine Other / unclassified 300 mg Oral
Comparator Clozapine Other / unclassified 600 mg Oral

Indications